ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
71.35
0.56%
US Dollar vs AUD
1.4477
-0.22%
Bitcoin
65,864.57
1.05%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Soligenix Inc (SNGX)

  7. Soligenix Inc (SNGX) News

SNGX

Soligenix (SNGX)

Soligenix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNGX
DateTimeSourceHeadlineSymbolCompany
16/09/202421:30PR Newswire (US)Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024NASDAQ:SNGXSoligenix Inc
03/09/202421:30PR Newswire (US)Soligenix Receives European Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
17/08/202406:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SNGXSoligenix Inc
17/08/202406:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
10/08/202406:09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
10/08/202406:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
10/08/202406:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNGXSoligenix Inc
09/08/202421:30PR Newswire (US)Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial ResultsNASDAQ:SNGXSoligenix Inc
05/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNGXSoligenix Inc
01/08/202423:00GlobeNewswire Inc.Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian PoligoneNASDAQ:SNGXSoligenix Inc
25/07/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
16/07/202400:16GlobeNewswire Inc.PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study ResultsNASDAQ:SNGXSoligenix Inc
10/07/202403:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
09/07/202421:30PR Newswire (US)Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
25/06/202421:30PR Newswire (US)Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
14/06/202421:30PR Newswire (US)A Comparison of Vaccine Technologies to be Presented at the ASM Microbe ConferenceNASDAQ:SNGXSoligenix Inc
05/06/202422:00GlobeNewswire Inc.Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication TrialNASDAQ:SNGXSoligenix Inc
31/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
31/05/202421:30PR Newswire (US)Soligenix Announces Reverse Stock SplitNASDAQ:SNGXSoligenix Inc
30/05/202406:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNGXSoligenix Inc
29/05/202421:30PR Newswire (US)Soligenix Encourages Stockholders to Vote their Shares at the Annual MeetingNASDAQ:SNGXSoligenix Inc
29/05/202406:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNGXSoligenix Inc
25/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
24/05/202421:30PR Newswire (US)Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual MeetingNASDAQ:SNGXSoligenix Inc
23/05/202421:30PR Newswire (US)Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock SplitNASDAQ:SNGXSoligenix Inc
23/05/202406:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNGXSoligenix Inc
22/05/202402:35GlobeNewswire Inc.PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the HorizonNASDAQ:SNGXSoligenix Inc
21/05/202421:30PR Newswire (US)SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX ConferenceNASDAQ:SNGXSoligenix Inc
20/05/202421:30PR Newswire (US)Soligenix Encourages Stockholders to Vote Prior to Annual MeetingNASDAQ:SNGXSoligenix Inc
18/05/202406:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
 Showing the most relevant articles for your search:NASDAQ:SNGX

Your Recent History

FX
AUDUSD
AUD vs US Dollar
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
ASX
TLS
Telstra
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
ASX
WDC
Westfield
ASX
CSL
CSL
NYSE
VZ
Verizon Communications
ASX
XJO
S&P ASX 200
ASX
FMG
Fortescue
NASDAQ
AAPL
Apple
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved